Type 1 Diabetes Mellitus, diabetic, Type 1 diabetes, T1DM, siplizumab, Diabetes Mellitus, Diabetes Mellitus, Type 1
Lead Scientist at UCSF
- Stephen Gitelman, M.D.
Dr. Gitelman is a physician scientist involved in studies to determine what causes type 1 diabetes mellitus (T1DM), and in clinical trials to prevent disease development, or preserve beta cell function in those recently diagnosed. To this end, he has been an active investigator in the NIH-sponsored TrialNet and Immune Tolerance Network consortia, and other immunotherapy trials in T1DM.
- not yet accepting patients
- Start Date
- Completion Date
- National Institute of Allergy and Infectious Diseases (NIAID)
- Immune Tolerance Network (ITN) National Institute of Allergy and Infectious Diseases (NIAID) Division of Allergy, Immunology, and Transplantation (DAIT)
- Phase 1/2 research study
- Study Type
- Expecting 120 study participants
- Last Updated